AI subjects had higher rates of diabetes mellitus (AI 63.5% vs. non-AI 38.7% p=< 0.001) and were more likely to require insulin treatment of their diabetes mellitus (AI 36.5% vs. non-AI 17.2% p=< 0.001). This evidence concerns the gene INS and diabetes mellitus.